CoChat

Synergistic effects of common schizophrenia risk variants

Open access
Schrode, Nadine, Ho, Seok-Man, Yamamuro, Kazuhiko, Dobbyn, Amanda, Huckins, Laura, Matos, Marliette R., Cheng, Esther, Deans, P. J. Michael, Flaherty, Erin, Barretto, Natalie, Topol, Aaron, Alganem, Khaled, Abadali, Sonya, Gregory, James, Hoelzli, Emily, Phatnani, Hemali, Singh, Vineeta, Girish, Deeptha, Aronow, Bruce, Mccullumsmith, Robert, Hoffman, Gabriel E., Stahl, Eli A., Morishita, Hirofumi, Sklar, Pamela, Brennand, Kristen J. · 2019 · Nature Genetics
Cited by 234

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Abstract

The mechanisms by which common risk variants of small effect interact to contribute to complex genetic disorders are unclear. Here, we apply a genetic approach, using isogenic human induced pluripotent stem cells, to evaluate the effects of schizophrenia (SZ)-associated common variants predicted to function as SZ expression quantitative trait loci (eQTLs). By integrating CRISPR-mediated gene editing, activation and repression technologies to study one putative SZ eQTL (FURIN rs4702) and four top-ranked SZ eQTL genes (FURIN, SNAP91, TSNARE1andCLCN3), our platform resolves pre- and postsynaptic neuronal deficits, recapitulates genotype-dependent gene expression differences and identifies convergence downstream of SZ eQTL gene perturbations. Our observations highlight the cell-type-specific effects of common variants and demonstrate a synergistic effect between SZ eQTL genes that converges on synaptic function. We propose that the links between rare and common variants implicated in psychiatric disease risk constitute a potentially generalizable phenomenon occurring more widely in complex genetic disorders. Combinatorial perturbation of schizophrenia risk loci in human induced pluripotent stem cell–derived neuronal cells demonstrates a synergistic effect converging on synaptic function.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41588-019-0497-5

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 36

  1. Pardiñas, A. F. et al. Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection. Nat. Genet. 50, 381–389 (2018). · DOI · Paper page
  2. Hall, L. S. et al. A transcriptome wide association study implicates specific pre- and post-synaptic abnormalities in schizophrenia. Preprint at bioRxiv https://doi.org/10.1101/384560 (2018). · DOI
  3. Huckins, L. M. et al. Gene expression imputation across multiple brain regions provides insights into schizophrenia risk. Nat. Genet. 51, 659–674 (2019). · DOI · Paper page
  4. Dobbyn, A. et al. Landscape of conditional eQTL in dorsolateral prefrontal cortex and co-localization with schizophrenia GWAS. Am. J. Hum. Genet. 102, 1169–1184 (2018). · DOI · Paper page
  5. Hoffman, G. E. et al. Transcriptional signatures of schizophrenia in hiPSC-derived NPCs and neurons are concordant with post-mortem adult brains. Nat. Commun. 8, 2225 (2017). · DOI · Paper page
  6. Fromer, M. et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat. Neurosci. 19, 1442–1453 (2016). · DOI · Paper page
  7. Forrest, M. P. et al. Open chromatin profiling in hiPSC-derived neurons prioritizes functional noncoding psychiatric risk variants and highlights neurodevelopmental loci. Cell Stem Cell 21, 305–318.e8 (2017). · DOI
  8. Darmanis, S. et al. A survey of human brain transcriptome diversity at the single cell level. Proc. Natl Acad. Sci. USA 112, 7285–7290 (2015). · DOI · Paper page
  9. Ho, S. M. et al. Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells. Methods 101, 113–124 (2016). · DOI · Paper page
  10. Ho, S. M. et al. Evaluating synthetic activation and repression of neuropsychiatric-related genes in hiPSC-derived NPCs, neurons, and astrocytes. Stem Cell Rep. 9, 615–628 (2017). · DOI
  11. Canals, I. et al. Rapid and efficient induction of functional astrocytes from human pluripotent stem cells. Nat. Methods 15, 693–696 (2018). · DOI · Paper page
  12. Bowles, K. R., Tcw, J., Qian, L., Jadow, B. M. & Goate, A. M. Reduced variability of neural progenitor cells and improved purity of neuronal cultures using magnetic activated cell sorting. PLoS ONE 14, e0213374 (2019). · DOI · Paper page
  13. Hou, Y. et al. Schizophrenia-associated rs4702 G allele-specific downregulation of FURIN expression by miR-338-3p reduces BDNF production. Schizophr. Res. 199, 176–180 (2018). · DOI
  14. Mowla, S. J. et al. Biosynthesis and post-translational processing of the precursor to brain-derived neurotrophic factor. J. Biol. Chem. 276, 12660–12666 (2001). · DOI · Paper page
  15. Campenot, R. B. Local control of neurite development by nerve growth factor. Proc. Natl Acad. Sci. USA 74, 4516–4519 (1977). · DOI · Paper page
  16. McGuire, J. L. et al. Altered serine/threonine kinase activity in schizophrenia. Brain Res. 1568, 42–54 (2014). · DOI
  17. Petralia, R. S. et al. Reduction of AP180 and CALM produces defects in synaptic vesicle size and density. Neuromolecular Med. 15, 49–60 (2013). · DOI · Paper page
  18. Smith, J. J., Sumiyama, K. & Amemiya, C. T. A living fossil in the genome of a living fossil: Harbinger transposons in the coelacanth genome. Mol. Biol. Evol. 29, 985–993 (2012). · DOI
  19. Chun, S. et al. Thalamic miR-338-3p mediates auditory thalamocortical disruption and its late onset in models of 22q11.2 microdeletion. Nat. Med. 23, 39–48 (2017). · DOI
  20. Föcking, M. et al. Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Mol. Psychiatry 20, 424–432 (2015). · DOI · Paper page
  21. Ripke, S., Schizophrenia Working Group & O’Donovan, M. Current status of schizophrenia GWAS. Eur. Neuropsychopharmacol. 27, S415 (2017). · doi:10.1016/j.euroneuro.2016.09.460
  22. Takata, A., Matsumoto, N. & Kato, T. Genome-wide identification of splicing QTLs in the human brain and their enrichment among schizophrenia-associated loci. Nat. Commun. 8, 14519 (2017). · DOI · Paper page
  23. Bardy, C. et al. Neuronal medium that supports basic synaptic functions and activity of human neurons in vitro. Proc. Natl Acad. Sci. USA 112, E2725–E2734 (2015). · DOI · Paper page
  24. Kwon, H. B. et al. Neuroligin-1-dependent competition regulates cortical synaptogenesis and synapse number. Nat. Neurosci. 15, 1667–1674 (2012). · DOI · Paper page
  25. Dityatev, A., Dityateva, G. & Schachner, M. Synaptic strength as a function of post- versus presynaptic expression of the neural cell adhesion molecule NCAM. Neuron 26, 207–217 (2000). · DOI · Paper page
  26. Suk, H. J. et al. Closed-loop real-time imaging enables fully automated cell-targeted patch-clamp neural recording in vivo. Neuron 96, 244–245 (2017). · DOI
  27. Port, F. & Bullock, S. L. Augmenting CRISPR applications in Drosophila with tRNA-flanked sgRNAs. Nat. Methods 13, 852–854 (2016). · DOI · Paper page
  28. Hoffman, G. E., Schrode, N., Flaherty, E. & Brennand, K. J. New considerations for hiPSC-based models of neuropsychiatric disorders. Mol. Psychiatry 24, 49–66 (2019). · DOI
  29. Ballouz, S. & Gillis, J. Strength of functional signature correlates with effect size in autism. Genome Med. 9, 64 (2017). · DOI
  30. Jia, P., Chen, X., Fanous, A. H. & Zhao, Z. Convergent roles of de novo mutations and common variants in schizophrenia in tissue-specific and spatiotemporal co-expression network. Transl. Psychiatry 8, 105 (2018). · DOI
  31. Wray, N. R., Wijmenga, C., Sullivan, P. F., Yang, J. & Visscher, P. M. Common disease is more complex than implied by the core gene omnigenic model. Cell 173, 1573–1580 (2018). · DOI · Paper page
  32. Mimitou, E. P. et al. Multiplexed detection of proteins, transcriptomes, clonotypes and CRISPR perturbations in single cells. Nat. Methods 16, 409–412 (2019). · DOI · Paper page
  33. McMahon, F. J. & Insel, T. R. Pharmacogenomics and personalized medicine in neuropsychiatry. Neuron 74, 773–776 (2012). · DOI
  34. Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493–1501 (2016). · DOI · Paper page
  35. Hoffman, G. E. & Schadt, E. E. variancePartition: interpreting drivers of variation in complex gene expression studies. BMC Bioinformatics 17, 483 (2016). · DOI · Paper page
  36. Wu, D. & Smyth, G. K. Camera: a competitive gene set test accounting for inter-gene correlation. Nucleic Acids Res. 40, e133 (2012). · DOI · Paper page

Cited by

See all 234

Metadata

Authors
Schrode, N., Ho, S.-M., Yamamuro, K., Dobbyn, A., Huckins, L., Matos, M. R., Cheng, E., Deans, P. J. M., Flaherty, E., Barretto, N., Topol, A., Alganem, K., Abadali, S., Gregory, J., Hoelzli, E., Phatnani, H., Singh, V., Girish, D., Aronow, B., Mccullumsmith, R., Hoffman, G. E., Stahl, E. A., Morishita, H., Sklar, P., & Brennand, K. J.
Venue
Nature Genetics
Published
2019-09-23
Volume
51
Issue
10
Pages
1475-1485
ISSN
  • 1061-4036 (ISSN-L)
  • 1546-1718
OpenAlex
W2974103075
Cited by
234
References
39
FWCI
22.49
Type
journal article
Language
en
Open access
green
Licence
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R56 MH101454, R01 MH106056, R01 MH109897)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synergistic effects of common schizophrenia risk variants. https://app.cochat.ai/papers/10.1038/s41588-019-0497-5
The paper
Schrode, N., Ho, S.-M., Yamamuro, K., Dobbyn, A., Huckins, L., Matos, M. R., Cheng, E., Deans, P. J. M., Flaherty, E., Barretto, N., Topol, A., Alganem, K., Abadali, S., Gregory, J., Hoelzli, E., Phatnani, H., Singh, V., Girish, D., Aronow, B., . . . Brennand, K. J. (2019). Synergistic effects of common schizophrenia risk variants. Nature Genetics. https://doi.org/10.1038/s41588-019-0497-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.